Insights

Stay Up to Date on the Latest News and Events from SLW

United States Trade Representative 2025 National Trade Estimate Report on Foreign Trade Barriers – China Needs to Increase Damages and Criminal Penalties for IP Infringement

On March 31, 2025, the United States Trade Representative (USTR) released their 2025 National Trade Estimate Report on Foreign Trade Barriers, with the longest section being dedicated to China at 47 pages.  With respect to intellectual property, the USTR acknowledged that China has issued some final measures relating to implementation of the IP chapter of […]

China’s National Intellectual Property Administration Releases 2025 Budget and Targets – Expecting Over 5 Million Patent Applications in 2025

On March 26, 2025, China’s National Intellectual Property Administration (CNIPA) released its 2025 budget (国家知识产权局2025年部门预算) listing performance targets. Some 2025 targets include: receiving over 5.135 million invention and utility model patent applications; lowering the examination period for invention patents to 15 months or less; examining 2.026 million invention patent applications; 4,500 or more people will […]

China’s National Intellectual Property Administration: Accelerate the Use of AI in Examination

On March 28, 2025, China’s National Intellectual Property Administration (CNIPA) held a press conference to discuss their work goals in light of the recent National People’s Congress and to “implement the spirt of General Secretary Xi Jinping’s important speech” at the Congress.  Heng Fuguang, spokesperson and director of CNIPA stated it will implement that spirit […]

China Releases Draft Implementation Measures for the Protection of Drug Trial Data Including Data Exclusivity for Foreign-Originated Drugs

On March 19, 2025, China’s National Medical Products Administration (NMPA) released Implementation Measures for the Protection of Drug Trial Data (Trial, Draft for Comments) (药品试验数据保护实施办法(试行,征求意见稿))and Working Procedures for the Protection of Drug Trial Data (Draft for Comments) (药品试验数据保护工作程序(征求意见稿)) that provides up to 6 years of data exclusivity of clinical trial data required to be submitted […]

Regulations on the Implementation of the Anti-Foreign Sanctions Law of the People’s Republic of China – Foreign-Owned Intellectual Property Can Be Seized

On March 23, 2025, the State Council of the People’s Republic of China promulgated the Regulations on the Implementation of the Anti-Foreign Sanctions Law of the People’s Republic of China (实施〈中华人民共和国反外国制裁法〉的规定). Article 7 of the Regulations specifically allows for the seizure of intellectual property of those that “directly or indirectly participate in the drafting, decision-making, […]

CNIPA and 6 Other Chinese Government Bodies Issue Opinions on Further Improving the Business Environment in the Field of Intellectual Property – New Trademark Law Coming?

On March 21, 2025, China’s National Intellectual Property Administration (CNIPA) and 6 other government bodies released the “Opinions of the CNIPA, the Ministry of Education, the Ministry of Science and Technology, the State Administration for Market Regulation, the State Financial Regulatory Administration, the National Copyright Administration and the Chinese Academy of Sciences on further optimizing […]